Pfizer: all 4,072 studies
Page 34 of 41. Open to participants first (153), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating the Safety and Tolerability of NSA-789CompletedNCT00633048Phase 1
- Study Evaluating the Efficacy of an Ibuprofen Effervescent Tablet in the Treatment of Post-Surgical Dental PainCompletedNCT00631111Phase 3
- A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing HomesCompletedNCT00630851Phase 3
- Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference FormulationCompletedNCT00630435Phase 1
- A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLSCompletedNCT00627003Phase 3
- A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.TerminatedNCT00625833Phase 2
- A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLSCompletedNCT00625547Phase 3
- A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking MethotrexateCompletedNCT00620685Phase 2
- Study Evaluating Multiple Ascending Dose in Schizophrenia PatientsTerminatedNCT00620568Phase 1
- A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy VolunteersCompletedNCT00619931Phase 1
- Study Evaluating the Safety, Tolerability and Pharmacokinetics of NSA-789 in Healthy Japanese Male SubjectsCompletedNCT00619736Phase 1
- Complicated Skin and Skin Structure InfectionsCompletedNCT00619710Phase 3
- A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered TogetherCompletedNCT00618124Phase 1
- Effect of PF-00734200 in Subjects With Type 2 DiabetesCompletedNCT00618007Phase 2
- Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)CompletedNCT00617760Phase 3
- A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid TumorsCompletedNCT00615446Phase 1
- PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic NeuralgiaCompletedNCT00614705Phase 2
- A 14-week, Multi-center Study of [S,S]-Reboxetine in Patients With Fibromyalgia.CompletedNCT00612170Phase 3
- A Phase I, Single Dose Study Of PF-04360365 In Japanese Patients With Mild To Moderate Alzheimer's DiseaseCompletedNCT00607308Phase 1
- Long-term OL Study of [S,S]-RBX in Patients With FibromyalgiaTerminatedNCT00607256Phase 3
- A Study to Evaluate the Blood Levels, Safety, and Tolerability of PF-00734200 in Subjects With Impaired Kidney Function and Normal Kidney FunctionCompletedNCT00596518Phase 1
- Treatment Use Study for Advanced Melanoma.No longer availableNCT00584493
- Study Evaluating Prevenar Immunogenicity in High Risk ChildrenCompletedNCT00581620Phase 4
- Study Evaluating the Tolerability of Bifeprunox in Healthy SubjectsCompletedNCT00581451Phase 1
- Study Evaluating Approach to Treatment of Haemophilia A and B in SpainCompletedNCT00581438
- Study Evaluating Safety and Tolerability of Ascending Multiple Dose of SLV-313 in Schizophrenia PatientsTerminatedNCT00581243Phase 1
- Study Evaluating the Safety and Tolerability of Single Ascending Dose (SAD) SLV-351 in Healthy SubjectsTerminatedNCT00581191Phase 1
- Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith EtanerceptCompletedNCT00581165Phase 4
- Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia BCompletedNCT00581126Phase 4
- Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same TimeCompletedNCT00581035Phase 4
- Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in ChildrenCompletedNCT00580684Phase 4
- Study Evaluating Workload, Clinical and Therapeutic Management of Psoriatic ArthritisCompletedNCT00580632
- Evaluation Of PF-00572778 And Alprazolam On Naloxone Challenge In Healthy SubjectsTerminatedNCT00580190Phase 1
- Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of SchizophreniaCompletedNCT00580125Phase 2
- Study Of The Safety And Pharmacokinetics Of CE-326,597 In Patients With Asymptomatic GallstonesCompletedNCT00576589Phase 1
- Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus AureusCompletedNCT00572559Phase 4
- A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary InsomniaCompletedNCT00569972Phase 2
- A Study Of Adjunctive Treatment Of Cognitive Deficits In SchizophreniaCompletedNCT00567203Phase 1
- A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's DiseaseCompletedNCT00566397Phase 2
- Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029CompletedNCT00563810Phase 1
- Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and DigoxinCompletedNCT00563732Phase 1
- Double-Blind, Four Week Trial Of [S,S]-Reboxetine And Atomoxetine In Adults With Attention Deficit Hyperactivity Disorder.WithdrawnNCT00562055Phase 2
- A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).CompletedNCT00559910Phase 2
- Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant PatientsWithdrawnNCT00556257Phase 2
- A Dose-ranging, Multicenter Polysomnography Trial of PD 0200390 in Adults With Primary InsomniaCompletedNCT00551148Phase 2
- Study Evaluating Bazedoxifene/CE in Postmenopausal WomenCompletedNCT00550433Phase 1
- Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy SubjectsCompletedNCT00550381Phase 1
- Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid ArthritisCompletedNCT00550355Phase 1
- Bioequivalence Study Of Glucotrol XL 2.5 Mg TabletsCompletedNCT00550329
- Study Comparing Formulations of Bazedoxifene/Conjugated EstrogensCompletedNCT00550303Phase 1
- Study Evaluating Multiple Doses Of GSI-953 Within The Elderly PopulationCompletedNCT00547560Phase 1
- First Safety Study in Humans of a Single Dose of CPG 52364CompletedNCT00547014Phase 1
- Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious PatientsCompletedNCT00546923Phase 4
- Study Evaluating the Efficacy and Safety of EtanerceptCompletedNCT00546533Phase 4
- Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining RemissionCompletedNCT00546494Phase 4
- Single Ascending Dose of GAP-134 as a 24-hour IV Infusion in Healthy Japanese MalesCompletedNCT00543946Phase 1
- Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal WomenCompletedNCT00543790Phase 1
- Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal WomenCompletedNCT00543634Phase 1
- A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety DisorderCompletedNCT00542685Phase 3
- A Study of ARRY-371797 in Subjects Undergoing Third Molar ExtractionCompletedNCT00542035Phase 2
- A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body WeightCompletedNCT00542009Phase 2
- Study Comparing Bioavailability of Oral Formulations of VabicaserinCompletedNCT00541996Phase 1
- Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy SubjectsCompletedNCT00538889Phase 1
- An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male VolunteersCompletedNCT00537615Phase 1
- ACTiF- Assessment of Closed Tibial FracturesCompletedNCT00533377Phase 2
- Single-Dose Safety Study of APD791 in Healthy VolunteersCompletedNCT00529646Phase 1
- A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCLTerminatedNCT00529503Phase 2
- A Study To Find The Best Dose Of SU011248 When Given With Pemetrexed, Pemetrexed And Cisplatin Or Pemetrexed And Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00528619Phase 1
- A Study of Lintuzumab (SGN-33) in Combination With Low Dose Cytarabine in Patients 60+ Years With AMLCompletedNCT00528333Phase 2
- Study Evaluating IMA-026 in Healthy Japanese MalesCompletedNCT00528099Phase 1
- Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult SmokersCompletedNCT00527150Phase 1
- Effects Of An Oral Growth Hormone Secretagogue In Older Functionally Limited AdultsTerminatedNCT00527046Phase 2
- Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU SubjectsCompletedNCT00526760Phase 3
- Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple MyelomaCompletedNCT00525447Phase 1
- Phase I Trial of PX-478CompletedNCT00522652Phase 1
- Study Evaluating TRU-015 in B-Cell Non-Hodgkin's LymphomaTerminatedNCT00521638Phase 1
- Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy SubjectsCompletedNCT00519298Phase 1
- Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant PatientsCompletedNCT00519116Phase 4
- Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500CompletedNCT00518492Phase 1
- Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With SirolimusCompletedNCT00518375Phase 4
- Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft RecipientsCompletedNCT00518271Phase 2
- Study Evaluating IMA-026 in Healthy SubjectsCompletedNCT00517348Phase 1
- Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid TumorsCompletedNCT00511849Phase 1
- A Study to Assess an Auto-injector Being Used to Treat a Migraine AttackCompletedNCT00510419Phase 3
- Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of GAP-134 Administered IntravenouslyCompletedNCT00510029Phase 1
- Study Evaluating FXR-450 in Healthy Japanese MenTerminatedNCT00509756Phase 1
- Study Evaluating Serum Collected From Healthy Adults For Development of Pneumococcal Opsonophagocytic AssayCompletedNCT00508950Not applicable
- Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving SirolimusCompletedNCT00507793Phase 4
- A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles OutbreakWithdrawnNCT00506610Phase 2
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male SubjectsCompletedNCT00505973Phase 1
- TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)CompletedNCT00503529Phase 4
- Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in JapanCompletedNCT00503503
- Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male SubjectsCompletedNCT00502879Phase 1
- A Phase I Study of Lintuzumab Combined With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS)CompletedNCT00502112Phase 1
- Study Evaluating the Pharmacokinetics of the Potential Drug Interaction Between HCV-796 and DesipramineCompletedNCT00500721Phase 1
- Blood Collection for Use in Serological Assay Development From Healthy Adult VolunteersCompletedNCT00500032Not applicable
- Study Evaluating the Effect of Lecozotan SR on the QTc IntervalCompletedNCT00499642Phase 1
- Study Evaluating the Safety of FXR-450 in Healthy SubjectsCompletedNCT00499629Phase 1
- Study Evaluating 3 New Formulations of SKI-606 in Healthy Adult SubjectsCompletedNCT00499538Phase 1
- Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor OccupancyCompletedNCT00499200Phase 1